Innate Pharma (IPHA) Short Interest Ratio & Short Volume $2.14 -0.01 (-0.47%) Closing price 08/7/2025 03:51 PM EasternExtended Trading$2.10 -0.04 (-1.82%) As of 08/7/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Innate Pharma Short Interest DataInnate Pharma (IPHA) has a short interest of 52,000 shares. This marks a -14.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 13,407 shares to cover all short positions.Current Short Interest52,000 sharesPrevious Short Interest60,700 sharesChange Vs. Previous Month-14.33%Dollar Volume Sold Short$92.04 thousandShort Interest Ratio2.9 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares92,180,000 sharesPercentage of Shares Shorted0.06%Today's Trading Volume2,898 sharesAverage Trading Volume13,407 sharesToday's Volume Vs. Average22% Short Selling Innate Pharma? Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPHA Short Interest Over TimeIPHA Days to Cover Over TimeIPHA Percentage of Float Shorted Over Time Innate Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202552,000 shares $92.04 thousand -14.3%N/A2.9 $1.77 6/30/202560,700 shares $110.17 thousand +17.9%0.1%3.1 $1.82 6/15/202551,500 shares $97.59 thousand -8.4%0.1%2.1 $1.90 5/31/202556,200 shares $121.39 thousand -14.5%0.1%2.4 $2.16 5/15/202565,700 shares $138.63 thousand -82.5%0.1%1.9 $2.11 4/30/2025376,100 shares $838.70 thousand -2.6%N/A1.7 $2.23 4/15/2025386,100 shares $737.45 thousand -5.2%0.7%1.7 $1.91 3/31/2025407,300 shares $724.99 thousand -2.4%0.7%1.8 $1.78 3/15/2025417,100 shares $812.93 thousand -9.6%0.7%1.8 $1.95 2/28/2025461,400 shares $978.17 thousand +199.2%0.8%0.7 $2.12 Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025154,200 shares $299.15 thousand +1.1%0.3%0.2 $1.94 1/31/2025152,500 shares $279.08 thousand +44.7%N/A0.3 $1.83 1/15/2025105,400 shares $179.18 thousand +4.4%N/A0.2 $1.70 12/31/2024101,000 shares $185.84 thousand -88.9%N/A0.2 $1.84 12/15/2024909,800 shares $2.75 million +1,344.1%N/A2 $3.02 11/30/202463,000 shares $97.02 thousand -1.1%N/A0.3 $1.54 11/15/202463,700 shares $91.73 thousand -2.3%N/A6.2 $1.44 10/31/202465,200 shares $123.29 thousand +10.9%N/A7.8 $1.89 10/15/202458,800 shares $119.36 thousand -18.1%N/A7.4 $2.03 9/30/202471,800 shares $164.42 thousand +20.3%N/A10 $2.29 9/15/202459,700 shares $134.92 thousand -8.3%N/A9 $2.26 8/31/202465,100 shares $149.40 thousand -2.5%N/A9.3 $2.30 8/15/202466,800 shares $150.30 thousand +3.6%N/A8.1 $2.25 7/31/202464,500 shares $138.35 thousand -11.5%N/A7.8 $2.15 7/15/202472,900 shares $154.55 thousand +5.2%N/A9.1 $2.12 6/30/202469,300 shares $134.44 thousand -4.9%N/A7.7 $1.94 6/15/202472,900 shares $171.32 thousand +4.1%N/A7 $2.35 5/31/202470,000 shares $191.80 thousand -0.3%N/A6.7 $2.74 5/15/202470,200 shares $175.94 thousand -11.3%N/A7.2 $2.51 4/30/202479,100 shares $182.72 thousand -2.7%N/A8.8 $2.31 4/15/202481,300 shares $196.75 thousand +5.7%N/A7.8 $2.42 3/31/202476,900 shares $221.47 thousand -13.7%N/A7.7 $2.88 3/15/202489,100 shares $217.40 thousand +13.7%N/A7.6 $2.44 2/29/202478,400 shares $205.41 thousand -4.9%N/A4.1 $2.62 2/15/202482,400 shares $212.59 thousand +8.4%N/A4.7 $2.58 1/31/202476,000 shares $203.68 thousand -0.9%N/A4 $2.68 1/15/202476,700 shares $214.76 thousand -8.9%N/A3.7 $2.80 12/31/202384,200 shares $235.76 thousand +55.9%N/A3.9 $2.80 12/15/202354,000 shares $130.14 thousand -5.9%N/A2.6 $2.41 11/30/202357,400 shares $137.76 thousand -4.3%N/A4.3 $2.40Critical AI announcement set to ignite AI 2.0 (Ad)Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet. That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions.Click here to watch how it works—and why it could give smaller traders an edge before the next big m 11/15/202360,000 shares $147.60 thousand -6.0%N/A4.2 $2.46 10/31/202363,800 shares $151.84 thousand +11.5%N/A4.4 $2.38 10/15/202357,200 shares $132.42 thousand -8.5%N/A5 $2.32 9/30/202362,500 shares $158.13 thousand -3.4%N/A6 $2.53 9/15/202364,700 shares $192.16 thousand -1.5%N/A6.7 $2.97 8/31/202365,700 shares $191.32 thousand -8.1%N/A5.2 $2.91 8/15/202371,500 shares $206.64 thousand -3.8%N/A6.1 $2.89 7/31/202374,300 shares $218.44 thousand -1.9%N/A6.8 $2.94 7/15/202375,700 shares $244.51 thousand -3.8%N/A6.4 $3.23 6/30/202378,700 shares $242.00 thousand +20.0%N/A6.1 $3.08 6/15/202365,600 shares $213.86 thousand +9.7%N/A4 $3.26 5/31/202359,800 shares $175.81 thousand -4.3%N/A3.8 $2.94 5/15/202362,500 shares $186.88 thousand No ChangeN/A3.6 $2.99 10/31/2022147,600 shares $317.34 thousand +12.8%N/A12.9 $2.15 10/15/2022130,900 shares $261.80 thousand +15.5%N/A12.5 $2.00 9/30/2022113,300 shares $226.60 thousand +1.3%N/A12.7 $2.00 9/15/2022111,900 shares $284.23 thousand +2.3%N/A13.3 $2.54 8/31/2022109,400 shares $293.19 thousand +0.2%N/A6.4 $2.68 8/15/2022109,200 shares $321.05 thousand -10.1%N/A5.9 $2.94 7/31/2022121,500 shares $388.79 thousand -3.6%N/A6.1 $3.20 7/15/2022126,000 shares $347.76 thousand +0.3%N/A4.9 $2.76 6/30/2022125,600 shares $339.12 thousand +3.9%N/A4.8 $2.70 6/15/2022120,900 shares $305.88 thousand +1.9%N/A4.6 $2.53 5/31/2022118,700 shares $315.74 thousand -13.6%N/A6.2 $2.66 5/15/2022137,300 shares $394.05 thousand +8.0%N/A6.7 $2.87 4/30/2022127,100 shares $364.78 thousand -9.3%N/A5.7 $2.87 4/15/2022140,100 shares $438.51 thousand +4.0%N/A6 $3.13 3/31/2022134,700 shares $452.59 thousand +105.0%N/A5.3 $3.36 3/15/202265,700 shares $207.61 thousand +13.9%N/A1.6 $3.16 2/28/202257,700 shares $196.76 thousand -2.5%N/A1 $3.41 2/15/202259,200 shares $219.63 thousand -15.6%N/A0.9 $3.71 1/31/202270,100 shares $265.68 thousand -15.3%N/A1 $3.79 1/15/202282,800 shares $375.08 thousand -22.3%N/A1.1 $4.53 12/31/2021106,600 shares $486.10 thousand +247.2%N/A1.3 $4.56 12/15/202130,700 shares $158.11 thousand +0.3%N/A0.3 $5.15 11/30/202130,600 shares $151.78 thousand -39.8%N/A0 $4.96 11/15/202150,800 shares $263.65 thousand +195.4%N/A0 $5.19 10/29/202117,200 shares $99.76 thousand +18.6%N/A0 $5.80 10/15/202114,500 shares $85.12 thousand -89.5%N/A0 $5.87 9/30/2021137,800 shares $850.23 thousand +79.7%N/A0.1 $6.17 9/15/202176,700 shares $427.99 thousand +2,456.7%N/A0 $5.58 8/31/20213,000 shares $10.92 thousand -45.5%N/A0 $3.64 8/13/20215,500 shares $18.70 thousand -35.3%N/A0.3 $3.40 7/30/20218,500 shares $28.22 thousand -33.6%N/A0.5 $3.32 7/15/202112,800 shares $41.47 thousand +100.0%N/A0.7 $3.24 6/30/20216,400 shares $21.06 thousand -61.0%N/A0.4 $3.29 6/15/202116,400 shares $65.76 thousand +1,161.5%N/A1.1 $4.01 5/28/20211,300 shares $5.08 thousand +225.0%N/A0.1 $3.91 5/14/2021400 shares $1.58 thousand -81.8%N/A0 $3.95 4/30/20212,200 shares $9.42 thousand -29.0%N/A0.1 $4.28Critical AI announcement set to ignite AI 2.0 (Ad)Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet. That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions.Click here to watch how it works—and why it could give smaller traders an edge before the next big m 4/15/20213,100 shares $13.58 thousand -55.7%N/A0 $4.38 3/31/20217,000 shares $30.03 thousand -6.7%N/A0.2 $4.29 3/15/20217,500 shares $34.28 thousand +53.1%N/A0.2 $4.57 2/26/20214,900 shares $21.66 thousand -27.9%N/A0.1 $4.42 2/12/20216,800 shares $30.80 thousand +385.7%N/A0.2 $4.53 1/29/20211,400 shares $5.74 thousand -74.1%N/A0 $4.10 1/15/20215,400 shares $24.52 thousand -77.2%N/A0.2 $4.54 12/31/202023,700 shares $102.15 thousand -52.5%N/A0.9 $4.31 12/15/202049,900 shares $219.06 thousand +91.2%N/A2.5 $4.39 11/30/202026,100 shares $145.12 thousand -7.1%N/A1.5 $5.56 11/15/202028,100 shares $133.48 thousand -23.2%N/A1.6 $4.75 10/30/202036,600 shares $146.22 thousand +21.6%N/A2.5 $4.00 10/15/202030,100 shares $121.00 thousand +32.6%N/A2.5 $4.02 9/30/202022,700 shares $87.17 thousand -22.5%N/A2.2 $3.84 9/15/202029,300 shares $127.46 thousand +70.4%N/A2.9 $4.35 8/31/202017,200 shares $106.81 thousand -5.5%N/A2.2 $6.21 8/14/202018,200 shares $119.21 thousand -40.9%N/A2.3 $6.55 IPHA Short Interest - Frequently Asked Questions What is Innate Pharma's current short interest? Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 52,000 shares of IPHA short. Learn More on Innate Pharma's current short interest. What is a good short interest ratio for Innate Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHA shares currently have a short interest ratio of 3.0. Learn More on Innate Pharma's short interest ratio. Is Innate Pharma's short interest increasing or decreasing? Innate Pharma saw a drop in short interest in July. As of July 15th, there was short interest totaling 52,000 shares, a drop of 14.3% from the previous total of 60,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Innate Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Innate Pharma: CorMedix Inc (14.82%), Immatics N.V. (3.15%), Oculis Holding AG (0.06%), Nuvation Bio Inc. (31.53%), uniQure N.V. (15.75%), Pharming Group N.V. Sponsored ADR (0.00%), Cronos Group Inc. (1.27%), AnaptysBio, Inc. (35.48%), GH Research PLC (6.22%), Ginkgo Bioworks Holdings, Inc. (27.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Innate Pharma stock? Short selling IPHA is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. IPHA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innate Pharma? A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHA, which in turn drives the price of the stock up even further. How often is Innate Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies CorMedix Short Interest Immatics Short Interest Oculis Short Interest Nuvation Bio Short Interest uniQure Short Interest Pharming Group Short Interest Cronos Group Short Interest AnaptysBio Short Interest GH Research Short Interest Ginkgo Bioworks Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPHA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
